This teaser pitch has been around for a few weeks, but I haven’t gotten around to covering it until now… call it marijuana fatigue, just plain laziness, or a surfeit of other hypetastic pitches, but it just didn’t rise to the top. Questions have rolled in from readers pretty consistently, though, so I’m finally digging […]
Articles
- Most Relevant
- Most Recent
Here’s the lead-in to the ad that caught our readers’ attention this week: “This ‘Perfect Storm’ Stock Is Set to Deliver Big Pharma a Swift and Devastating DEATHBLOW It Won’t Come Back From… “And Launch This Little Company on A 72-Hour, $8.98 Billion All-Out SPRINT” And there’s a deadline… today, in fact, when there will […]
Today we’re looking at a teaser pitch from Larry Edelson, who thinks that the government is on the verge of outlawing cash and forcing you to use credit cards and other digital payments. And, of course, he has a way to enrich you as this trend proceeds… buying the companies who are doing the payment […]
This is really disappointing. All this time I’ve been under the impression that your friendly neighborhood Stock Gumshoe and his terrifically handsome likeness were all the “female Viagra” the world needed … but apparently some pharmaceutical companies disagree, and have been trying to develop a drug along those lines. At least, that’s the pitch from […]
[ed. note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who writes for us a couple times a month about health issues and trends. He does not typically focus on specific investment opportunities, but has agreed to our trading restrictions… as with all of our authors, […]
Alpha Contracts! That’s what’s being teased by the Agora Financial folks these days, all as part of a pitch for Zachary Scheidt’s Contract Income Alert. And they’ve been teased before, but I had a bunch of readers pile on with questions this week — probably thanks to that new “July 22” deadline — so I […]
OK, OK, the questions on this one are getting a bit overwhelming — and I’m afraid that if I don’t cover this one soon the villagers will soon be gathering their fiery torches and marching on Castle Gumshoe … so here goes. Louis Basenese and the folks at Wall Street Daily are pitching his MicroCap […]
This ad has been floating to the top of my inbox for a couple days now, and since the people have spoken I thought I better write about it right quick for you — I am, after all, your humble sleuthing servant. Well, OK, maybe not so humble all the time, but do you want […]
This one comes in from the folks at Investors Daily Edge, in an ad for a new service of theirs called The Bond Trader, run by a guy named Steve McDonald. So you will not be shocked to hear that this teaser is about investing in debt, not in equity — lending your money to […]
I generally don’t like to write about super-heavily-hyped microcap stocks for the whole Gumshoe readership, because we’re almost guaranteed to cause a spike in the price for that stock. So when I saw the latest teaser for the Phase 1 folks over at Stansberry, and those teasers always cause a huge flood of emails to […]
Dawn of the Planet of the TLOGlodytes![Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own, and he has agreed to our trading restrictions.] Want to see something really cool? A hot video clip from a steamy biotech thriller? Watch this. Better yet, when you pull up the video viewing frame, […]
Hey Travis, I received this in an email this morning and was wondering if you know the stock. Thanks! Craig Now, a promise like this would be preposterous coming from anyone else … however, when a person with Paul’s credentials comes forward, one is practically required to pay attention. After all, Paul’s $6 billion hedge […]
I’m just copying this all from the promo because I can’t figure out what it means. What it promises definitely might look promising, perhaps. Herewith, my paste: 26 years before the birth of Bitcoin, three rogue entrepreneurs created a radical new investment. A venture that turned every $10 stake into $11,899 over 19 years. It […]
I’m just copying this all from the promo because I can’t figure out what it means. What it promises definitely might look promising, perhaps. Herewith, my paste: 26 years before the birth of Bitcoin, three rogue entrepreneurs created a radical new investment. A venture that turned every $10 stake into $11,899 over 19 years. It […]
[ed note: Michael Jorrin, who I like call “Doc Gumshoe,” is a longtime medical writer who shares his thoughts with us a couple times a month — his articles are non-financial in nature, his words and opinions are his own, and you can see his bio and his past pieces here. Enjoy!] Indulge me while […]
[ed note: This is another installment from our favorite medical writer, Doc Gumshoe (no, he’s not a doctor, but we like the way he analyzes and explains medical issues for our readers). Since he’s talking about specific companies this time, we’ve restricted the piece to the Irregulars and have inserted some comments about the stocks […]
Well, yesterday we went through the first two picks that Patrick Cox is teasing as his “7 breakthrough companies” that will bring us our next “printing press moment” and change the world (while inflating your wallet). If you want to catch up with the rest of the group, that article is here. So let’s move […]
This week I’ve got a little teaser decipherization for you to get us started, and we’ve also got a new piece from Dr. KSS… and I’ve got some updated thoughts on a few other stocks at the end of today’s piece. The teaser? Well, it’s been circulating for a few weeks now, and it caught […]
This particular ad hasn’t actually been completely lambasting my inbox this week, which is a surprise since the “cure for obesity” stocks usually gin up quite a bit of interest — being overweight is, after all, the plague of our time of overabundance and the cause of so many of our ills, both social and […]
Today we’re digging into a teaser ad that mentions several little companies, most of which appear to be in biotech … and which is so terribly urgent that they have to “this presentation from the Internet at 5pm Thursday, March 31st.” So, golly gee, we’ve only got one more day! Quick! The promise will sound […]
I shared a brief Trade Note yesterday about the sale of part of my position in Innovative Industrial Properties (IIPR), and I promised to go much more in depth in my thinking today… so strap yourself in. (And if you don’t care about IIPR at all or aren’t interested in “bear attacks”, you can skip […]
A version of this story first appeared on January 22, when we first saw Christian DeHaemer’s ad. The ad has been very lightly updated in recent months and is being heavily promoted now, so I’ve gone through and updated this article and my thinking to reflect the coronavirus collapse and any updates the companies have […]
Today we’re taking a little side path into the gold markets, since gold has recently shown a little spike of enthusiasm following talk of bailouts, and we’ve gotten a bunch of questions about Gerardo Del Real’s “Tier 2 Gold” teaser pitch for Junior Mining Monthly ($99/yr). So what is he talking about? Well, like most […]
Gerado Del Real is promoting Tier 2 Gold as a way to buy gold as low as $10 per oz and 26,000% gains. The concept is to buy junior miners who have proven reserves. He discusses 3 junior miners and states one is in Idaho with 3 million ounces, one in Mexico with 4.4 million […]
Hi, Really appreciate your input regarding various stocks and opportunities to take advantage of or leave alone. I was wondering about Mr. Gerardo Del Real and his latest offer to sign up to Junior Mining Monthly. Most of what Mr. Del Real was selling was the opportunity to have the inside track to purchase stocks […]
anyone know about his #1 Gold play at $1.35 or subscribe to his Strategic Intelligence I’ve spent alot on these subscriptions and hasn’t worked out well.
Personal Finance ($39 for the first year) is a relative low cost “entry level” investment newsletter, the kind that all the big publishers use to recruit the wave of new subscribers who get fed into their marketing “funnel” that generates leads for their higher-priced services… though, to be fair, we also often hear from readers […]
Please indulge Doc Gumshoe while he presents his musings on what’s going on in general in the health-care arena, and in particular, which new drugs are getting the FDA blessing and why, as well as which ones are getting the short straw. My impressions and conclusions are in some cases only loosely based on […]
To find out you need to subscribe to Passive Monthly Income from Lombardi. Cost: $49 for first six months, then will rebill for annual $295 Cancellation: possible Excerpt: ”Companies hand out these little-known lump-sum cash payments that are up to 38 times bigger than the regular quarterly dividends they pay!” ”Have you heard of ”Section […]
For some reason, the investment newsletter audience (and their publishers) find “anti-aging” pitches quite appealing… maybe it’s because so many of us are reaching those “golden years” and wondering how to extend them without pain or poverty. I’m not quite in the “core” demographic yet at 49, but I’ve got the knees and hips of […]
This week I’m seeing a new wave of questions about this Jim Rickards ad from Agora, and the ad itself has been (clumsily) updated a few times since we covered it back in November of 2017 (the last version with the “by March 19, 2019” deadline even suggested that Yellen was still President of the […]
Innovative Industrial Properties (IIPR) hit a stop loss yesterday thanks to a sector-wide collapse of marijuana stocks. The big news that hits IIPR directly this week was that MedMen dropped its plan to buy PharmaCann, which is IIPR’s biggest tenant, so I did take the somewhat cautious step of buying a few protective puts just […]
The competition for your brokerage account has gotten fierce again, which is great news for investors. There’s no longer any reason to pay brokerage commissions for buying or selling stock… which makes it so much easier for small individual shareholders to be slow and gradual in their portfolio-building, and I think that’s great — don’t […]
From where I sit, it seems to me that the entire landscape of Alzheimer’s disease (AD) has changed, and changed quite significantly. The litany of announcements from pharmaceutical companies big and small revealing the unfortunate news that yet another promising agent for the treatment of AD has failed to meet its objectives in a […]
We first published this teaser solution on January 8, and I’m continuing to get the ad forwarded to me here at Gumshoe HQ pretty much every day… so I thought I’d repost this solution and provide you with a bit of an update (the story has changed a little, and I’ve learned a little more […]
Robert Ross is peddling his Yield Shark newsletter from Mauldin Economics, and he’s doing it with an all-too-familiar “enroll in this income stream” kind of idea… in his case, he calls it the “Social Security Catastrophe Plan” and implies that it can “Boost Your Retirement by $185,040 Today.” Like most such offerings, there’s an undercurrent […]
Remember when an Apple product event used to be exciting? Waiting on pins and needles for that “one more thing” to be pulled out of a hat by Steve Jobs? Those memories made yesterday’s product intros just plain depressing (slightly better iPads! Slightly better phones! Guess what price our streaming service will be!) … but […]
Gold had its worst day yesterday since 2016, so that was a little shock to the system — mostly, I think, because the latest leaks and Tweets about the China trade dispute were relatively optimistic, with meetings scheduled for next month. It’s hard to imagine we’re going to have a “real” trade deal before the […]
Today we’ve got another “profit from the trade war pitch,” with Casey Research peddling a special report called “De-Fang the Red Dragon and Make 11X Your Money” as they troll for subscribers to Nick Giambruno’s Crisis Investing ($1,795 at the moment, no refunds… though you can transfer the sub to something else from Bonner, Palm […]
If newsletter guys know anything, it’s how to sell gold investments — gold has been at the core of the newsletter hype industry since the 1980s, attracting ornery gold bugs every time the gold price rises a bit, so we’re seeing most publishers running quickly to the virtual mailbox with their gold pitches these days… […]